Today: 26 April 2026
Nike’s 1,400 Job Cuts Reveal the Hard Part of Its Sneaker Comeback
26 April 2026
2 mins read

Nike’s 1,400 Job Cuts Reveal the Hard Part of Its Sneaker Comeback

BEAVERTON, Oregon, April 26, 2026, 07:04 PDT

Nike, Inc. is eliminating roughly 1,400 jobs worldwide, targeting technology positions most heavily as it tries to speed up its turnaround and simplify operations. That’s nearly 2% of its employees across the globe.

The timing here is key: Chief Executive Elliott Hill’s turnaround strategy is now hitting Nike’s core operations, after earlier efforts on products and branding. The company has been struggling with a prolonged sales downturn, losing ground on retail shelves to nimbler competitors like On, Hoka, and Anta.

U.S. equity markets closed for the weekend saw Nike finish Friday at $44.69, slipping 0.2%. That leaves the company’s market cap hovering around $66.2 billion. The share price has been grinding lower, stretching investor patience as the turnaround drags on.

Nike is pulling much of its tech work into two main hubs: the Philip H. Knight Campus in Beaverton and its India Technology Center. The company also confirmed shifts in work locations, restructuring of teams, and adjustments to headcount within Global Operations.

Chief Operating Officer Venkatesh Alagirisamy told staff in a memo, “This is not a new direction. It is the next phase of the work already underway.” According to the memo, the company is in the “final stretch” of its Win Now plan—a program targeting culture, product, marketing, marketplace, and physical retail presence. Business Insider

This restructuring reaches beyond software or data. Nike is reworking staffing at its Air Manufacturing Innovation sites in Beaverton, St. Louis, and Vietnam. Some Converse footwear manufacturing and engineering roles are being shifted closer to factory partners. Parts of the materials supply chain are now being integrated into the footwear and apparel teams.

The layoffs come against a tough backdrop for Nike. Third-quarter revenue landed at $11.3 billion, matching last year’s tally, but Nike Direct sales slipped 4%. Gross margin took a 130 basis point hit, down to 40.2%, as higher North American tariffs weighed.

Hill, in March’s results statement, pointed to “meaningful actions” already underway, though he cautioned that “the work is not finished.” Finance chief Matthew Friend noted the Win Now efforts will continue to pressure results for the rest of the calendar year. Nike

The cuts don’t solve Nike’s core problem: costs might drop faster than demand recovers. The company is bracing for sales to dip 2% to 4% this quarter—China, in particular, could tumble 20%. Morningstar’s David Swartz put it plainly to Reuters, saying the layoffs point to “problems run deeper than originally thought.” Reuters

Nike has already logged a hefty tab for its restructuring. For the nine months ended Feb. 28, filings show the company booked $304 million in estimated pretax severance tied to layoffs. More cuts could be on the table, with Nike warning it might take further steps that may push charges higher in coming quarters.

Nike is pushing for fewer layers and greater automation to move products faster—a key concern in a segment where running shoes and lifestyle sneakers can shift pace in a hurry. According to CIO Dive, the company’s tech-centered job cuts land as firms reevaluate staffing and funnel more spending into AI and automation.

The notifications started going out to affected staff on Thursday, the company memo showed. Alagirisamy said the moves are designed to make Nike “less complex and more responsive”—which boils down to a critical question: Can a slimmer Nike bring shoppers back before competitors grab more ground? sfchronicle.com

Stock Market Today

  • Cramer Highlights Risks of Concentrated AI Stock Investments and Healthcare Sector Decline
    April 26, 2026, 1:06 PM EDT. Jim Cramer warns the stock market faces a shortage of broad investment as funds disproportionately flow into AI-related stocks tied to data center buildouts. This concentration has left sectors like defense and healthcare, particularly pharmaceuticals and life sciences, under severe pressure. Companies such as Thermo Fisher and Danaher face harsh market reactions despite solid fundamentals and quarterly results. Medical device maker Abbott Labs and drug distributor Cardinal Health also grapple with declining stock prices, reflecting a wider investor retreat from healthcare. Even Johnson & Johnson, despite strong earnings, has seen its stock drop due to poor technical charts. Cramer suggests that increasing overall market inflows could stabilize these struggling sectors and bring balance to the current investment landscape.

Latest article

COHR Stock Faces a May Test After CFO’s $702,000 Sale

COHR Stock Faces a May Test After CFO’s $702,000 Sale

26 April 2026
Coherent Corp CFO Sherri Luther sold 2,000 shares for $702,000 on April 22, according to an SEC filing. The sale comes ahead of Coherent’s fiscal third-quarter results, set for May 6. Coherent shares last traded at $336.09, below Luther’s sale price of $351. Nvidia invested $2 billion in Coherent in March, securing future access to laser and optical networking products.
Trump Media Shake-Up Deepens: DJT Board Adds Trump Allies as New CEO Gets Stock Grant

Trump Media Shake-Up Deepens: DJT Board Adds Trump Allies as New CEO Gets Stock Grant

26 April 2026
Trump Media disclosed interim CEO Kevin McGurn will earn $125,000 a month for nine months and receive 146,198 restricted stock units, according to a Friday filing. Meredith O’Rourke and Boris Epshteyn joined the board effective April 24. Devin Nunes has exited all roles, with separation terms including accelerated vesting of 96,721 RSUs. DJT shares last traded at $9.35.
AXT Stock Has a $632.5 Million Question: Can Its China Wafer Bet Keep Up With AI Demand?

AXT Stock Has a $632.5 Million Question: Can Its China Wafer Bet Keep Up With AI Demand?

26 April 2026
AXT underwriters bought 1.28 million additional shares at $64.25 each, raising $82.5 million and bringing total gross proceeds to about $632.5 million. The funds will expand indium phosphide wafer capacity at Beijing Tongmei, its China-based subsidiary. AXT expects first-quarter revenue of $26–28 million and a net loss of up to $2.6 million. Shares closed at $76.16 on April 24.
Berkshire Hathaway’s $370 Billion Question: Greg Abel Faces First Big Test After Warren Buffett
Previous Story

Berkshire Hathaway’s $370 Billion Question: Greg Abel Faces First Big Test After Warren Buffett

Constellation Energy’s Three Mile Island Restart Faces a 73-Million-Gallon Test
Next Story

Constellation Energy’s Three Mile Island Restart Faces a 73-Million-Gallon Test

Go toTop